Rigel Pharmaceuticals
RIGL
#6648
Rank
NZ$1.47 B
Marketcap
NZ$78.32
Share price
4.42%
Change (1 day)
27.56%
Change (1 year)

Rigel Pharmaceuticals (RIGL) Fails to deliver data

Key failure to deliver metrics for Rigel Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Rigel Pharmaceuticals (RIGL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Rigel Pharmaceuticals (RIGL) - since 2013

Volume in USD (price x number of shares), data since 2013

Rigel Pharmaceuticals (RIGL) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$0.03 M-97.08%
2023NZ$1.11 M-68.64%
2022NZ$3.56 M-47.14%
2021NZ$6.75 M159.94%
2020NZ$2.59 M284.04%
2019NZ$0.67 M-85.02%
2018NZ$4.51 M17.28%
2017NZ$3.85 M24.72%
2016NZ$3.08 M166.47%
2015NZ$1.15 M-47.8%
2014NZ$2.21 M151.65%
2013NZ$0.88 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
NZ$25.92 MNZ$0.45 B๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
N/ANZ$0.14 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
NZ$1.32 MNZ$5.69 M๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
NZ$0.23 MNZ$0.23 M๐Ÿ‡บ๐Ÿ‡ธ USA